Appeals court rejects NJ pharma challenges to Medicare drug pricing

A federal appeals court rejected challenges by major pharmaceutical companies to Medicare drug price negotiations. Read More

Appeals court sides with Medicare in fight over drug price power

Philadelphia, PA – A federal appeals court has upheld the Biden administration’s authority to negotiate Medicare drug prices, rejecting claims by pharmaceutical giants Bristol Myers Squibb and Janssen ... Read More

Novartis Loses Court Appeal Over Medicare Drug Price Negotiation

The Trump administration notched a win Thursday in a challenge from Novartis AG to the Biden-era program that allows the US to negotiate drug prices for some of the most widely used and expensive ... Read More

10 Big Medicare Changes in 2026: Higher Premiums, Drug Price Drops, and Looming Program Cuts

Medicare beneficiaries face higher premiums and deductibles, reduced services, and possible cuts to the program at large—but there’s good news about prices for some drugs, and the medication payment ... Read More

Kennedy Says Medicare Drug Price Talks Were ‘Poorly Structured’

The Biden-era Medicare Drug Price Negotiation Program was poorly structured and has ended up raising costs for the government, US Health Secretary Robert F. Kennedy Jr. told senators Thursday. Read More

Medicare's Latest Drug Price Deal Could Save Billions for Seniors

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic. Read More